September 2025
1. GRAFF-RADFORD J, Syrjanen JA, Vemuri P, Lowe VJ, et al
   Predictive Value of Plasma Biomarkers in Tau-PET Transitions.
   Ann Neurol. 2025 Sep 10. doi: 10.1002/ana.78003.
   

   >> Share

   
   
2. BUCKLEY RF, Scott M, McGrath ER, Coughlan G, et al
   Midlife Steroid-Binding Globulin Levels and In Vivo Neuroimaging Measures of Tau in Older Men and Women.
   Ann Neurol. 2025;98:524-532.
   

   >> Share

   
   August 2025
3. LEON KE, Rauschecker AM, Chow FC
   Use of FDG-PET in Balamuthia mandrillaris Amebic Encephalitis.
   Ann Neurol. 2025 Aug 1. doi: 10.1002/ana.70012.
   

   >> Share

   
   June 2025
4. MILA-ALOMA M, Tosun D, Schindler SE, Hausle I, et al
   Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks.
   Ann Neurol. 2025 Jun 20. doi: 10.1002/ana.27285.
   

   >> Share

   
   
5. IAZZOLINO B, Palumbo F, Moglia C, Manera U, et al
   Frequency and Early Predictors of Cognitive Deterioration in Amyotrophic Lateral Sclerosis: A Longitudinal Population-Based Study.
   Ann Neurol. 2025;97:1122-1133.
   

   >> Share

   
   May 2025
6. BRAUN AS, Satoh R, Pham NTT, Singh-Reilly N, et al
   Machine Learning Models of Voxel-Level [(18)F] Fluorodeoxyglucose Positron Emission Tomography Data Excel at Predicting Progressive Supranuclear Palsy Pathology.
   Ann Neurol. 2025 May 30. doi: 10.1002/ana.27265.
   

   >> Share

   
   April 2025
7. SLINGERLAND S, van der Zee S, Carli G, Slomp AC, et al
   Cholinergic Degeneration and Cognitive Function in Early GBA1-Related Parkinson's Disease.
   Ann Neurol. 2025 Apr 16. doi: 10.1002/ana.27248.
   

   >> Share

   
   
8. LUO C, Nguyen TN, Li R, Tao C, et al
   Computed Tomography Perfusion Parameters: A Potential Tool for Treatment Selection in Basilar Artery Occlusion.
   Ann Neurol. 2025 Apr 2. doi: 10.1002/ana.27214.
   

   >> Share

   
   
9. BROWN EG, Chahine LM, Siderowf A, Gochanour C, et al
   Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha-Synuclein Disease.
   Ann Neurol. 2025;97:730-740.
   

   >> Share

   
   March 2025
10. DZIALAS V, Bischof GN, Mollenhoff K, Drzezga A, et al
    Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease.
    Ann Neurol. 2025 Mar 27. doi: 10.1002/ana.27223.
    

    >> Share

    
    
11. LAGARDE J, Maiti P, Schonhaut DR, Blazhenets G, et al
    Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts.
    Ann Neurol. 2025 Mar 17. doi: 10.1002/ana.27233.
    

    >> Share

    
    
12. ARRIOLA-INFANTE JE, Morcillo-Nieto AO, Zsadanyi SE, Franquesa-Mullerat M, et al
    Regional Brain Metabolism across the Alzheimer's Disease Continuum in Down Syndrome.
    Ann Neurol. 2025 Mar 14. doi: 10.1002/ana.27226.
    

    >> Share

    
    February 2025
13. CANOSA A, Manera U, Vasta R, Zocco G, et al
    Brain Metabolic Features of FUS-ALS: A 2-[(18)F]FDG-PET Study.
    Ann Neurol. 2025 Feb 20. doi: 10.1002/ana.27201.
    

    >> Share

    
    
14. KEUM M, Byun MS, Yi D, Ahn H, et al
    The Use of Antihypertensive Medication and In Vivo Alzheimer's Disease Pathology.
    Ann Neurol. 2025 Feb 17. doi: 10.1002/ana.27204.
    

    >> Share

    
    January 2025
15. LI J, Chen D, Tang Y, Chen Z, et al
    Synaptic Density Reductions in MSA: A Potential Biomarker Identified Through [(18)F]SynVesT-1 PET Imaging.
    Ann Neurol. 2025 Jan 19. doi: 10.1002/ana.27179.
    

    >> Share

    
    December 2024
16. KIM N, Ryu WS, Ha SY, Kim JY, et al
    Optimal Cerebral Blood Flow Thresholds for Ischemic Core Estimation Using Computed Tomography Perfusion and Diffusion-Weighted Imaging.
    Ann Neurol. 2024 Dec 26. doi: 10.1002/ana.27169.
    

    >> Share

    
    
17. BRIER MR, Judge B, Ying C, Salter A, et al
    Increased White Matter Aerobic Glycolysis in Multiple Sclerosis.
    Ann Neurol. 2024 Dec 23. doi: 10.1002/ana.27165.
    

    >> Share

    
    October 2024
18. ENGELS-DOMINGUEZ N, Riphagen JM, Van Egroo M, Koops EA, et al
    Lower Locus Coeruleus Integrity Signals Elevated Entorhinal Tau and Clinical Progression in Asymptomatic Older Individuals.
    Ann Neurol. 2024;96:650-661.
    

    >> Share

    
    September 2024
19. MUTIMER CA, Mujanovic A, Kaesmacher J, Churilov L, et al
    Comparison of Perfusion Imaging Definitions of the No-Reflow Phenomenon after Thrombectomy-What Is the Best Perfusion Imaging Definition?
    Ann Neurol. 2024 Sep 3. doi: 10.1002/ana.27073.
    

    >> Share

    
    
20. BRUMBERG J, Blazhenets G, Buhler S, Fostitsch J, et al
    Cerebral Glucose Metabolism Is a Valuable Predictor of Survival in Patients with Lewy Body Diseases.
    Ann Neurol. 2024;96:539-550.
    

    >> Share

    
    August 2024
21. BITZER F, Walger L, Bauer T, Schulte F, et al
    Higher Validity, Lower Radiation: A New Ictal Single-Photon Emission Computed Tomography Framework.
    Ann Neurol. 2024 Aug 21. doi: 10.1002/ana.27061.
    

    >> Share

    
    
22. HIRATA K, Matsuoka K, Tagai K, Endo H, et al
    In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy.
    Ann Neurol. 2024;96:247-261.
    

    >> Share

    
    June 2024
23. SOLEIMANI-MEIGOONI DN, Smith R, Provost K, Lesman-Segev OH, et al
    Head-to-Head Comparison of Tau and Amyloid Positron Emission Tomography Visual Reads for Differential Diagnosis of Neurodegenerative Disorders: An International, Multicenter Study.
    Ann Neurol. 2024 Jun 18. doi: 10.1002/ana.27008.
    

    >> Share

    
    May 2024
24. SAARINEN EK, Kuusimaki T, Lindholm K, Niemi K, et al
    Dietary Caffeine and Brain Dopaminergic Function in Parkinson Disease.
    Ann Neurol. 2024 May 20. doi: 10.1002/ana.26957.
    

    >> Share

    
    
25. LAN G, Chen X, Yang J, Sun P, et al
    Microglial Reactivity Correlates with Presynaptic Loss Independent of beta-Amyloid and Tau.
    Ann Neurol. 2024;95:917-928.
    

    >> Share

    
    April 2024
26. GARCIA-CORDERO I, Anastassiadis C, Khoja A, Morales-Rivero A, et al
    Evaluating the Effect of Alzheimer's Disease-Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy.
    Ann Neurol. 2024 Apr 5. doi: 10.1002/ana.26930.
    

    >> Share

    
    March 2024
27. ARNALDI D, Mattioli P, Raffa S, Pardini M, et al
    Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy.
    Ann Neurol. 2024 Mar 11. doi: 10.1002/ana.26902.
    

    >> Share

    
    
28. PAPP KV, Jutten RJ, Soberanes D, Weizenbaum E, et al
    Early Detection of Amyloid-Related Changes in Memory among Cognitively Unimpaired Older Adults with Daily Digital Testing.
    Ann Neurol. 2024;95:507-517.
    

    >> Share

    
    February 2024
29. LI Y, Yen D, Hendrix RD, Gordon BA, et al
    Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset.
    Ann Neurol. 2024 Feb 24. doi: 10.1002/ana.26891.
    

    >> Share

    
    
30. CHEN X, Toueg TN, Harrison TM, Baker SL, et al
    Regional Tau Deposition Reflects Different Pathways of Subsequent Neurodegeneration and Memory Decline in Cognitively Normal Older Adults.
    Ann Neurol. 2024;95:249-259.
    

    >> Share

    
    December 2023
31. BONOMI S, Lu R, Schindler SE, Bui Q, et al
    Relationships of Cognitive Measures with Cerebrospinal Fluid but not Imaging Biomarkers of Alzheimer Disease Vary between Black and White Individuals.
    Ann Neurol. 2023 Dec 1. doi: 10.1002/ana.26838.
    

    >> Share

    
    November 2023
32. CHUN MY, Chung SJ, Kim SH, Park CW, et al
    Hippocampal Perfusion Affects Motor and Cognitive Functions in Parkinson's Disease: An Early-Phase (18) F-FP-CIT PET Study.
    Ann Neurol. 2023 Nov 14. doi: 10.1002/ana.26827.
    

    >> Share

    
    October 2023
33. ZHENG L, Rubinski A, Dennecke J, Luan Y, et al
    Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer's Disease.
    Ann Neurol. 2023 Oct 14. doi: 10.1002/ana.26818.
    

    >> Share

    
    July 2023
34. PISANI L, Haussen DC, Mohammaden M, Perry da Camara C, et al
    Comparison of CT Perfusion Software Packages for Thrombectomy Eligibility.
    Ann Neurol. 2023 Jul 25. doi: 10.1002/ana.26748.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share